Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by InvrsContrarianon Jan 22, 2022 10:03pm
128 Views
Post# 34348981

RE:insider awards

RE:insider awardsI don't see what you are saying as true. Maybe for the old older option. But recently:"Jan. 20, 2022, Ventripoint Diagnostics Ltd. granted an aggregate of 1,725,000 options to directors, officers, employees, contractors and consultants of the corporation with an exercise price of 40 cents and with terms from one to 10 years and vesting from immediately to over three years. Of these option grants, 500,000 were awarded to directors and officers of the corporation. The corporation now has 4,096,590 options available for future grants under the stock option plan as approved by shareholders at the last special and annual general meeting on Aug. 9, 2021." Thats says spread out over 3 years. So they are. Looking at long term value. Glta
bluemoons20 wrote: Very nice to reward insiders  with options  under the market price.

However, to encourage  them  to work for their money, the  options etc,.  should be priced  above the current market  to  provide incentive to  raise the  shareprice and benefit themselves and the  shareholders , who are  actually  paying the bills.

This way  they  have a guaranteed gain  and only have to  hope  the price does  not go down  but  if it doesn't go up they are still OK.

If  we do eventually  get a buyout  you can bet  these 8 miullion options  will be right there to pick up their gain.  And this will further  dilute  the per share  buyout price  (if it exists)

GLTA shareholders


<< Previous
Bullboard Posts
Next >>